113 related articles for article (PubMed ID: 17366781)
1. [Immunotherapeutic effect of recombinant EGFR phage vaccine on tumors].
Liu D; Tang L; Zhou CC; Tan LS
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):728-32. PubMed ID: 17366781
[TBL] [Abstract][Full Text] [Related]
2. [An anti-tumor research of recombinant phage vaccine expressed xenogenic EGFR].
Zeng XZ; Liu D; Tang L; Zhou CC; Tan LS; Cai XH; Li XW; Zhou JN; Zhang PD; Zhang SQ
Shi Yan Sheng Wu Xue Bao; 2005 Dec; 38(6):481-9. PubMed ID: 16416965
[TBL] [Abstract][Full Text] [Related]
3. [Antitumor effect of recombinant T7 phage vaccine expressing xenogenic vascular endothelial growth factor on Lewis lung cancer in mice].
Li XH; Tang L; Liu D; Sun HM; Zhou CC; Tan LS; Wang LP; Zhang PD; Zhang SQ
Ai Zheng; 2006 Oct; 25(10):1221-6. PubMed ID: 17059764
[TBL] [Abstract][Full Text] [Related]
4. [Expression of xenogentic epidermal growth factor receptor ectodomain and its antitumor effect].
Li YH; Tang L; Liu Q; Chen DK; Tan LS
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Nov; 24(11):1051-4. PubMed ID: 18992189
[TBL] [Abstract][Full Text] [Related]
5. Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor.
Lu Y; Wei YQ; Tian L; Zhao X; Yang L; Hu B; Kan B; Wen YJ; Liu F; Deng HX; Li J; Mao YQ; Lei S; Huang MJ; Peng F; Jiang Y; Zhou H; Zhou LQ; Luo F
J Immunol; 2003 Mar; 170(6):3162-70. PubMed ID: 12626574
[TBL] [Abstract][Full Text] [Related]
6. Cancer immunotherapy by a recombinant phage vaccine displaying EGFR mimotope: an in vivo study.
Asadi-Ghalehni M; Ghaemmaghami M; Klimka A; Javanmardi M; Navari M; Rasaee MJ
Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):274-9. PubMed ID: 25990849
[TBL] [Abstract][Full Text] [Related]
7. A novel recombinant anti-epidermal growth factor receptor peptide vaccine capable of active immunization and reduction of tumor volume in a mouse model.
Asadi-Ghalehni M; Rasaee MJ; RajabiBazl M; Khosravani M; Motaghinejad M; Javanmardi M; Khalili S; Modjtahedi H; Sadroddiny E
Microbiol Immunol; 2017 Dec; 61(12):531-538. PubMed ID: 29023946
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor angiogenesis in lung cancer by T4 phage surface displaying mVEGFR2 vaccine.
Ren S; Fengyu ; Zuo S; Zhao M; Wang X; Wang X; Chen Y; Wu Z; Ren Z
Vaccine; 2011 Aug; 29(34):5802-11. PubMed ID: 21482223
[TBL] [Abstract][Full Text] [Related]
9. [Transformation activity and antigenicity of the human papillomavirus type 58 E6E7 fusion gene mutant].
Wang H; Yu JY; Li L
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):491-6. PubMed ID: 24257298
[TBL] [Abstract][Full Text] [Related]
10. Construction of a Recombinant Phage-vaccine Capable of Reducing the Growth Rate of an Established LL2 Tumor Model.
Asadi-Ghalehni M; Rasaee MJ; Namvar Asl N; Khosravani M; Rajabibazl M; Khalili S; Modjtahedi H; Sadroddiny E
Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):240-249. PubMed ID: 29908541
[TBL] [Abstract][Full Text] [Related]
11. Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses.
Shukla GS; Sun YJ; Pero SC; Sholler GS; Krag DN
J Immunol Methods; 2018 Sep; 460():51-62. PubMed ID: 29906453
[TBL] [Abstract][Full Text] [Related]
12. B-cell epitope peptide vaccination targeting dimer interface of epidermal growth factor receptor (EGFR).
Zhu L; Zhao L; Wu M; Chen Z; Li H
Immunol Lett; 2013 Jun; 153(1-2):33-40. PubMed ID: 23871733
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of endogenous mFlt4 displayed on a T4 phage nanoparticle surface.
Ren SX; Ren ZJ; Zhao MY; Wang XB; Zuo SG; Yu F
Acta Pharmacol Sin; 2009 May; 30(5):637-45. PubMed ID: 19417736
[TBL] [Abstract][Full Text] [Related]
14. [Construction and immunological analysis of a combined multi-epitope vaccine against EGFR/HER2].
Hu CP; Cai XT; Lu WG; Wang ZG; Ji XY; Cao P
Yao Xue Xue Bao; 2011 Nov; 46(11):1326-31. PubMed ID: 22260023
[TBL] [Abstract][Full Text] [Related]
15. [High expression of HPV16L2N120E7E6 fusion protein in E. coli and its inhibitory effect on tumor growth in mice].
Zhao L; Gao M; Gao J; Ren J; Zhang H; Tian HW; Tan WJ; Ruan L
Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):810-5. PubMed ID: 23291127
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumour research of recombinant BCG using BZLF1 and hGM-CSF fusion genes.
Xue QJ; Li YQ; Yang CQ; Chen T; Li XZ; Cheng B; Wang CM
Vaccine; 2017 Mar; 35(12):1599-1607. PubMed ID: 28228322
[TBL] [Abstract][Full Text] [Related]
17. Induction of anti-EGFR immune response with mimotopes identified from a phage display peptide library by panitumumab.
Wang A; Cui M; Qu H; Di J; Wang Z; Xing J; Wu F; Wu W; Wang X; Shen L; Jiang B; Su X
Oncotarget; 2016 Nov; 7(46):75293-75306. PubMed ID: 27659529
[TBL] [Abstract][Full Text] [Related]
18. [Antitumor effect of EGFRvIII/HBcAg recomibinant vaccine on murine transplanted tumor].
Duan XY; Wang JS; Guo YM; Wang P; Wang QY; Yang GX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):600-2. PubMed ID: 17618576
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary observation on antitumor effect of HPV58 composite DNA vaccine].
Wang H; Yu JY; Li L
Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):523-7. PubMed ID: 24284225
[TBL] [Abstract][Full Text] [Related]
20. [Construction and immunogenicity of recombinant bacteriophage T7 vaccine expressing M2e peptides of avian influenza virus].
Xu H; Wang YW; Tang YH; Zheng QS; Hou JB
Bing Du Xue Bao; 2013 Jun; 29(4):376-81. PubMed ID: 23895000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
